Vani Pharma Labs Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1976.
1976 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Vani Pharma Labs Limited

Vani Pharma Labs Limited, a active public limited company, was established on 15 June 1976 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24110TG1976PLC002040. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.40 Cr and a paid-up capital of ₹2.65 Cr.

Formerly known as Vani Chemicals & Intermediates Limited, Vani Chemicals & Intermediates P Ltd. It upholds a compliant status. Its leadership includes Chakradhar Mallampati (Managing Director), Kalyan Gadde (Director), Lakshmi Kranthi Mallampati (Additional Director). Past directors included Medempudi Ranga Rao, Sreehari Kumar Annamraju, Mallikharjun Rao Yalavarthi. It holds ₹48.80 Cr open charges and ₹15.34 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Plot No. 11, Industrial Development Area Ida Jeedimetla, Hyderabad, Telangana, 500055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110TG1976PLC002040

  • Registration Number

    002040

  • Incorporation Date

    15 June 1976

  • Authorized Capital

    ₹4.40 Cr

  • Paid-Up Capital

    ₹2.65 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.40 Cr
  • Paid Up Capital ₹ 2.65 Cr
  • Company Age 49 Year, 8 Months
  • Last Filing with ROC 31 Mar 2020
  • Open Charges ₹ 48.80 Cr
  • Satisfied Charges ₹ 15.34 Cr
  • Revenue Growth **** 40.44%
  • Profit Growth **** 61.30%
  • Ebitda **** 55.73%
  • Net Worth 78.65%
  • Total Assets **** 39.43%
Company report

Vani Pharma Labs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vani Pharma Labs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Vani Pharma Labs Limited?
Current Directors
Name Designation Appointment Date Status
Chakradhar Mallampati Managing Director 22 Dec 1998 Current
Kalyan Gadde Director 22 Dec 2017 Current
Lakshmi Kranthi Mallampati Additional Director 24 Dec 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 21 Sep 2008 Past
Pramod Abcsdd Additional Director 04 Oct 2023 Past
Pramod Abcsdd Whole-Time Director 01 Jun 2011 Past
Pramod Abcsdd Director 24 Dec 2021 Past
Pramod Abcsdd Whole-Time Director 07 Sep 2015 Past
Pramod Abcsdd Additional Director 04 Oct 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vani Pharma Labs.

Vani Pharma Labs Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 40.44% increase. The company also saw a substantial improvement in profitability, with a 61.3% increase in profit. The company's net worth Soared by an impressive increase of 78.65%.

Vani Pharma Labs revenue growth over time
Vani Pharma Labs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 40.44%
*******
*******
*******
*******
Revenue from Operations
*******
 39.64%
*******
*******
*******
*******
Total Assets
*******
 39.43%
*******
*******
*******
*******
Profit or Loss
*******
 61.30%
*******
*******
*******
*******
Net Worth
*******
 78.65%
*******
*******
*******
*******
EBITDA
*******
 55.73%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vani Pharma Labs?

In 2020, Vani Pharma Labs had a promoter holding of 46.31% and a public holding of 53.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹488,009,715.38

Satisfied Charges

₹153,397,000.00

Charges Breakdown by Lending Institutions
  • Others : 21.78 Cr
  • State Bank Of India : 14.50 Cr
  • Axis Bank Limited : 7.50 Cr
  • Standard Chartered Bank : 5.00 Cr
  • Gold Star Holding & Industries Limited : 0.02 Cr
  • Others : 0.01 Cr
Latest Charge Details
Date Lender Amount Status
09 Jun 2022 Standard Chartered Bank ₹5.00 Cr Open
11 May 2022 Axis Bank Limited ₹7.50 Cr Open
12 Nov 2020 Others ₹2.52 Cr Open
26 Jun 2020 Others ₹19.26 Cr Open
23 Nov 2018 State Bank Of India ₹14.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Vani Pharma Labs?

Unlock and access historical data on people associated with Vani Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vani Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vani Pharma Labs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vani Pharma Labs
Recent Activity within the Organization
  • Charges

    The activity A charge with Standard Chartered Bank amounted to Rs. 5.00 Cr with Charge ID 100581050 was registered on 09 Jun 2022. was completed.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 7.50 Cr with Charge ID 100579224 was registered on 11 May 2022. was completed.

  • Director Appointment

    Lakshmi Kranthi Mallampati was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 19.26 Cr registered on 26 Jun 2020 with Charge ID 100358673 was modified on 29 Apr 2021. was recorded as a recent event.

  • Annual General Meeting

    Progress on Vani Pharma Labs Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was documented.

  • Charges

    A charge with Others amounted to Rs. 2.52 Cr with Charge ID 100389650 was registered on 12 Nov 2020. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vani Pharma Labs Limited?

The CIN of Vani Pharma Labs Limited is U24110TG1976PLC002040.

Where is Vani Pharma Labs Limited headquartered?

Vani Pharma Labs Limited is headquartered at Plot No. 11, Industrial Development Area Ida Jeedimetla, Hyderabad, Telangana, 500055.

When was Vani Pharma Labs Limited incorporated?

Vani Pharma Labs Limited was incorporated on 15 June 1976.

Who are the current directors of Vani Pharma Labs Limited?

The current directors of Vani Pharma Labs Limited are

What is the primary industry of Vani Pharma Labs Limited?

The primary industry of Vani Pharma Labs Limited is Manufacturing.

Is Vani Pharma Labs Limited a listed company?

Vani Pharma Labs Limited is unlisted.

What is the capital structure of Vani Pharma Labs Limited?

The authorized capital of Vani Pharma Labs Limited is ₹4.40 Cr, and the paid-up capital is ₹2.65 Cr.

What is the compliance status of Vani Pharma Labs Limited?

The compliance status of Vani Pharma Labs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available